New Feature: A New Era for News on Finviz

Learn More

What To Expect From BrightSpring Health Services's (BTSG) Q4 Earnings

By Anthony Lee | February 25, 2026, 10:02 PM

BTSG Cover Image

Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) will be announcing earnings results this Friday before market hours. Here’s what to expect.

BrightSpring Health Services beat analysts’ revenue expectations last quarter, reporting revenues of $3.33 billion, up 14.7% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ revenue estimates and a beat of analysts’ EPS estimates.

Is BrightSpring Health Services a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting BrightSpring Health Services’s revenue to grow 10.8% year on year, slowing from the 28.6% increase it recorded in the same quarter last year.

BrightSpring Health Services Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. BrightSpring Health Services has missed Wall Street’s revenue estimates multiple times over the last two years.

Looking at BrightSpring Health Services’s peers in the senior health, home health & hospice segment, some have already reported their Q4 results, giving us a hint as to what we can expect. The Pennant Group delivered year-on-year revenue growth of 40.7%, missing analysts’ expectations by 3.5%, and Addus HomeCare reported revenues up 25.6%, in line with consensus estimates. Addus HomeCare traded down 10.6% following the results.

Read our full analysis of The Pennant Group’s results here and Addus HomeCare’s results here.

Investors in the senior health, home health & hospice segment have had fairly steady hands going into earnings, with share prices down 1.1% on average over the last month. BrightSpring Health Services is up 2.1% during the same time and is heading into earnings with an average analyst price target of $44.47 (compared to the current share price of $40.10).

P.S. STOP buying the AI stocks everyone's talking about. The real money? It’s in the profitable pick nobody’s watching yet. We’ve identified an AI profit machine that’s flying under Wall Street’s radar—for now. We can’t keep this research public forever—grab your FREE copy before we pull it offline. GO HERE NOW.

Latest News